An easily implementable serological assay to accurately detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies is urgently needed to better track herd immunity, ...
The COVID-19 pandemic has underscored the promise of monoclonal antibody-based drugs as prophylactic and therapeutic treatments for infectious disease. Multiple monoclonal antibody drug products that ...
During the current pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (Covid-19), has diversified considerably. As of September ...
The highly transmissible omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of mounting concern globally. The omicron variant carries a large number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results